134 related articles for article (PubMed ID: 1569651)
21. [An enzymatic determination of serum citrate with citrate lyase].
Yasukawa S; Ebisuno S; Morimoto S; Uehara M; Ohkawa T
Nihon Hinyokika Gakkai Zasshi; 1991 Nov; 82(11):1748-53. PubMed ID: 1762264
[TBL] [Abstract][Full Text] [Related]
22. Limited risk of kidney stone formation during long-term calcium citrate supplementation in nonstone forming subjects.
Sakhaee K; Baker S; Zerwekh J; Poindexter J; Garcia-Hernandez PA; Pak CY
J Urol; 1994 Aug; 152(2 Pt 1):324-7. PubMed ID: 8015062
[TBL] [Abstract][Full Text] [Related]
23. Prevention of recurrent calcium stone formation with potassium citrate therapy in patients with distal renal tubular acidosis.
Preminger GM; Sakhaee K; Skurla C; Pak CY
J Urol; 1985 Jul; 134(1):20-3. PubMed ID: 4009822
[TBL] [Abstract][Full Text] [Related]
24. Physiological and physiochemical correction and prevention of calcium stone formation by potassium citrate therapy.
Pak CY; Sakhaee K; Fuller CJ
Trans Assoc Am Physicians; 1983; 96():294-305. PubMed ID: 6679957
[TBL] [Abstract][Full Text] [Related]
25. Hypocitraturia in calcium nephrolithiasis.
Rudman D; Kutner MH; Redd SC; Waters WC; Gerron GG; Bleier J
J Clin Endocrinol Metab; 1982 Dec; 55(6):1052-7. PubMed ID: 7130336
[TBL] [Abstract][Full Text] [Related]
26. URINARY EXCRETION OF CALCIUM AND CITRATE IN NORMAL INDIVIDUALS AND STONE FORMERS WITH VARIATION IN CALCIUM INTAKE.
MCINTOSH HW; SERAGLIA M
Can Med Assoc J; 1963 Dec; 89(24):1242-3. PubMed ID: 14084708
[TBL] [Abstract][Full Text] [Related]
27. Urinary citrate, bone resorption and intestinal alkali absorption in stone formers with fasting hypercalciuria.
Messa P; Mioni G; Paganin L; Cruciatti A; Greco PL; Turrin D
Scanning Microsc; 1994; 8(3):531-8; discussion 538-9. PubMed ID: 7747155
[TBL] [Abstract][Full Text] [Related]
28. Bioavailability of potassium and magnesium, and citraturic response from potassium-magnesium citrate.
Koenig K; Padalino P; Alexandrides G; Pak CY
J Urol; 1991 Feb; 145(2):330-4. PubMed ID: 1988724
[TBL] [Abstract][Full Text] [Related]
29. Hypocitraturia in patients with gastrointestinal malabsorption.
Rudman D; Dedonis JL; Fountain MT; Chandler JB; Gerron GG; Fleming GA; Kutner MH
N Engl J Med; 1980 Sep; 303(12):657-61. PubMed ID: 7402252
[TBL] [Abstract][Full Text] [Related]
30. Increased calcium absorption in nephrolithiasis explained by uptake studies in ileal brush border membrane vesicles.
Ioannoni B; Chalmers AH
Biochem Med Metab Biol; 1994 Apr; 51(2):99-104. PubMed ID: 8043303
[TBL] [Abstract][Full Text] [Related]
31. Treatment Response in Patients with Stones, and Low Urinary pH and Hypocitraturia Stratified by Body Mass Index.
Astroza GM; Neisius A; Tsivian M; Preminger GM; Lipkin ME
J Urol; 2016 Mar; 195(3):653-7. PubMed ID: 26393903
[TBL] [Abstract][Full Text] [Related]
32. Reduction of renal stone risk by potassium-magnesium citrate during 5 weeks of bed rest.
Zerwekh JE; Odvina CV; Wuermser LA; Pak CY
J Urol; 2007 Jun; 177(6):2179-84. PubMed ID: 17509313
[TBL] [Abstract][Full Text] [Related]
33. Urinary patterns of patients with renal stones associated with chronic inflammatory bowel disease.
Trinchieri A; Lizzano R; Castelnuovo C; Zanetti G; Pisani E
Arch Ital Urol Androl; 2002 Jun; 74(2):61-4. PubMed ID: 12161938
[TBL] [Abstract][Full Text] [Related]
34. Magnesium bioavailability from magnesium citrate and magnesium oxide.
Lindberg JS; Zobitz MM; Poindexter JR; Pak CY
J Am Coll Nutr; 1990 Feb; 9(1):48-55. PubMed ID: 2407766
[TBL] [Abstract][Full Text] [Related]
35. [Citrate as an inhibitor of stone formation--with reference to intestinal citrate absorption and the influence of citrate on intestinal calcium absorption].
Yasukawa S; Uehara M; Yamauchi T; Morimoto S; Ebisuno S; Ohkawa T
Hinyokika Kiyo; 1991 Oct; 37(10):1103-6. PubMed ID: 1755398
[TBL] [Abstract][Full Text] [Related]
36. Effects of acute oral sodium potassium citrate load in healthy males--outlook for treatment of patients with calcium-containing renal stones.
Schwille PO; Rümenapf G; Köhler R; Sörgel F
Urol Int; 1987; 42(2):81-8. PubMed ID: 3617247
[TBL] [Abstract][Full Text] [Related]
37. Studies on citrate metabolism in normal subjects and kidney stone patients.
Minisola S; Rossi W; Pacitti MT; Scarnecchia L; Bigi F; Carnevale V; Mazzuoli G
Miner Electrolyte Metab; 1989; 15(5):303-8. PubMed ID: 2811789
[TBL] [Abstract][Full Text] [Related]
38. Successful treatment of hyperuricosuric calcium oxalate nephrolithiasis with potassium citrate.
Pak CY; Peterson R
Arch Intern Med; 1986 May; 146(5):863-7. PubMed ID: 3963975
[TBL] [Abstract][Full Text] [Related]
39. Urine citrate and renal stone disease.
Goldberg H; Grass L; Vogl R; Rapoport A; Oreopoulos DG
CMAJ; 1989 Aug; 141(3):217-21. PubMed ID: 2665909
[TBL] [Abstract][Full Text] [Related]
40. Potassium citrate decreases urine calcium excretion in patients with hypocitraturic calcium oxalate nephrolithiasis.
Song Y; Hernandez N; Shoag J; Goldfarb DS; Eisner BH
Urolithiasis; 2016 Apr; 44(2):145-8. PubMed ID: 26582172
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
